Kendall J. Schick

GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts.

Aaron J. Johnson, L. Pease, N. Kay, 2019, Blood.

Targeting Cancer-Associated Fibroblasts in the Bone Marrow Prevents Resistance to CART-Cell Therapy in Multiple Myeloma.

N. Kay, D. Jelinek, Yi Lin, 2022, Blood.

GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity

N. Kay, S. Sinha, M. Adada, 2022, Leukemia.

Leukemic Extracellular Vesicles Induce Chimeric Antigen Receptor T Cell Dysfunction in Chronic Lymphocytic Leukemia.

Yohan Kim, E. Braggio, N. Kay, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Optimized CART Cell Therapy for Metastatic Aggressive Thyroid Cancer

R. Smallridge, J. Copland, A. Zubair, 2024, bioRxiv.

Mesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppression.

R. Sakemura, Elizabeth L. Siegler, M. Hefazi, 2024, Nature biomedical engineering.

Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity

Aditya Bansal, M. Pandey, T. DeGrado, 2021, Cancer Immunology Research.

Improved Anti-Tumor Response of Chimeric Antigen Receptor T Cell (CART) Therapy after GM-CSF Inhibition Is Mechanistically Supported By a Novel Direct Interaction of GM-CSF with Activated Carts

N. Kay, S. Parikh, R. Sakemura, 2019, Biology of Blood and Marrow Transplantation.